What are the recommendations for aspirin use for primary prevention of ASCVD?
For primary prevention of ASCVD, it is recommended to avoid low-dose aspirin (75-100 mg orally daily). It should not be administered on a routine basis for adults over 70 years of age, nor for adults of any age who are at increased risk of bleeding. Aspirin should only be considered for primary prevention among select adults 40 to 70 years of age who are at higher ASCVD risk but not at increased risk of bleeding.